» Articles » PMID: 21242341

Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2011 Jan 19
PMID 21242341
Citations 170
Affiliations
Soon will be listed here.
Abstract

Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis.

Methods: The USPSTF evaluated evidence on the diagnostic accuracy of risk assessment instruments for osteoporosis and fractures, the performance of dual-energy x-ray absorptiometry and peripheral bone measurement tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug therapy for osteoporosis in women and men.

Recommendations: The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis in men. (I statement).

Citing Articles

Effects of Anticancer Therapy on Osteoporosis in Breast Cancer Patients: A Nationwide Study Using Data from the National Health Insurance Service-National Health Information Database.

Kwon M, Kim B, Min S, Chae S J Clin Med. 2025; 14(3).

PMID: 39941403 PMC: 11818878. DOI: 10.3390/jcm14030732.


Disparities in Dual-energy X-ray Absorptiometry Scan Utilization Across Race/Ethnic Groups Before and After Hip Fractures.

Rudisill K, Ratnasamy P, Sanchez J, Grauer J J Am Acad Orthop Surg Glob Res Rev. 2024; 8(9).

PMID: 39303221 PMC: 11419421. DOI: 10.5435/JAAOSGlobal-D-24-00052.


Knowledge and Practice toward DEXA Scan among Women in Jazan City, Saudi Arabia.

Dhayihi T, Haqawi N, Hakami S, Harthi F, Moafa S, Alawi Y Healthcare (Basel). 2024; 12(15).

PMID: 39120162 PMC: 11311830. DOI: 10.3390/healthcare12151459.


Bone health, cardiovascular disease, and imaging outcomes in UK Biobank: a causal analysis.

Condurache D, DAngelo S, Salih A, Szabo L, McCracken C, Mahmood A JBMR Plus. 2024; 8(6):ziae058.

PMID: 38784722 PMC: 11114472. DOI: 10.1093/jbmrpl/ziae058.


The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part I.

Lee D, Hong Y, Cho M, Choi Y, Chun S, Chung Y J Menopausal Med. 2024; 30(1):1-23.

PMID: 38714490 PMC: 11103071. DOI: 10.6118/jmm.24000.